INVESTABOT
Equity Research
XNYS · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Cencora (COR) had 1 Form 144 pre-sale notice filed on 2026-08-06. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Cencora (COR) had 1 Form 144 pre-sale notice filed on 2026-09-11. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Cencora (COR) had 1 Form 144 pre-sale notice filed on 2026-09-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Cencora (COR) had 1 Form 144 pre-sale notice filed on 2026-09-04. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Cencora (COR) had 1 Form 144 pre-sale notice filed on 2026-08-24. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 3 unique sellers · 7 accumulating - 6 trimming - 1 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 9/16/2026 | Greenberg Lon R | — | SELL | -1,280 | $321 | ~$0.4M |
| 9/1/2026 | Krikorian Lazarus | SVP & Chief Accounting Officer | SELL | -985 | $326 | ~$0.3M |
| 8/24/2026 | Campbell Elizabeth S | Executive Vice President | SELL | -11,300.47 | $324 | ~$3.7M |
| 7/31/2026 | Nally Dennis M | — | GRANT | 113 | $311 | ~$35K |
| 7/31/2026 | Cooper Ellen | — | GRANT | 97 | $311 | ~$30K |
| 7/31/2026 | Tyler Lauren M | — | GRANT | 97 | $311 | ~$30K |
| 6/30/2026 | Battaglia Silvana | Executive Vice President | GRANT | 58.2 | $241 | ~$14K |
| 6/30/2026 | Campbell Elizabeth S | Executive Vice President | GRANT | 49.89 | $241 | ~$12K |
| 6/29/2026 | Boratto Eva C | Chief Financial Officer | GRANT | 21,304 | — | — |
| 6/22/2026 | Tyler Lauren M | — | BUY | 550 | $270 | ~$0.1M |
| 6/18/2026 | Durcan Dermot Mark | — | BUY | 4,000 | $274 | ~$1.1M |
| 5/28/2026 | Durcan Dermot Mark | — | BUY | 4,000 | $266 | ~$1.1M |
| 5/1/2026 | Tyler Lauren M | — | GRANT | 99 | $304 | ~$30K |
| 5/1/2026 | Cooper Ellen | — | GRANT | 99 | $304 | ~$30K |
| 5/1/2026 | Nally Dennis M | — | GRANT | 116 | $304 | ~$35K |
| 4/1/2026 | Krikorian Lazarus | SVP & Chief Accounting Officer | GRANT | 3,936 | — | — |
| 3/11/2026 | Battaglia Silvana | Executive Vice President | OPTION_EXERCISE | 8,415 | — | — |
| 3/11/2026 | Battaglia Silvana | Executive Vice President | TAX_WITHHOLD | -3,673 | $350 | ~$1.3M |
| 3/11/2026 | Battaglia Silvana | Executive Vice President | OPTION_EXERCISE | -8,415 | — | — |
| 3/11/2026 | Campbell Elizabeth S | Executive Vice President | OPTION_EXERCISE | 12,623 | — | — |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| 6/30/2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 23,617,117 | ~$8.0B | — | 1/29/2026 |
| BlackRock | 20,286,079 | ~$6.9B | — | 2/12/2026 |
| BlackRock | 19,943,637 | ~$6.3B | -1.7% | 5/13/2026 |
| BlackRock | 18,213,783 | ~$5.2B | -8.7% | 8/7/2026 |
| BlackRock | 17,818,281 | ~$4.0B | — | 8/13/2024 |
| State Street | 9,305,507 | ~$3.1B | — | 2/13/2026 |
| State Street | 9,190,551 | ~$2.9B | -1.2% | 5/15/2026 |
| State Street | 9,273,983 | ~$2.6B | 0.9% | 8/7/2026 |
| Fidelity (FMR) | 6,686,269 | ~$2.1B | 22.5% | 5/15/2026 |
| Fidelity (FMR) | 5,459,637 | ~$1.8B | — | 2/17/2026 |
| JP Morgan Chase | 4,982,557 | ~$1.7B | — | 2/11/2026 |
| JP Morgan Chase | 5,943,657 | ~$1.7B | 21.7% | 8/12/2026 |
| JP Morgan Chase | 4,885,478 | ~$1.5B | -1.9% | 5/13/2026 |
| Morgan Stanley | 4,531,912 | ~$1.4B | 55.0% | 5/15/2026 |
| Fidelity (FMR) | 4,122,371 | ~$1.2B | -38.4% | 8/13/2026 |
| Morgan Stanley | 4,086,271 | ~$1.2B | -9.8% | 8/13/2026 |
| Morgan Stanley | 2,924,809 | ~$987.9M | — | 5/27/2026 |
| Goldman Sachs | 2,165,073 | ~$731.3M | — | 3/25/2026 |
| Goldman Sachs | 2,226,088 | ~$699.3M | 2.8% | 5/15/2026 |
| Goldman Sachs | 2,322,448 | ~$657.2M | 4.3% | 8/14/2026 |